De Koning HJ, et al. Effects of volume CT lung cancer screening: mortality results of the NELSON randomised-controlled population based trial. IASLC 2018, abstract PL02.05.
Tucatinib verlengt mediane overleving met 5,5 maand in finale analyse HER2CLIMB-studie
mrt 2022 | Borstkanker